1. "2024"
Formats
  1. Journal Article (2329)
  2. Meeting Abstract (1694)
  3. Review (589)
  4. Editorial (305)
  5. Book Section (98)
  6. Correspondence (92)
  7. Guidelines (90)
  8. Research Letter (89)
  9. Miscellaneous (55)
  10. Conference Paper (33)
  11. Book Whole (3)
Groups
  1. Department of Medicine (2141)
  2. Solid Tumor Oncology Division (1382)
  3. Sloan Kettering Institute Postdocs (1038)
  4. Surgery (984)
  5. Graduate Medical Education (883)
  6. GSK Faculty (868)

More Groups

People
  1. Eileen O'Reilly (75)
  2. Saad Usmani (75)
  3. Edward Christopher Dee (70)
  4. Nadeem Abu-Rustum (70)
  5. Alice Wei (69)
  6. T Peter Kingham (68)

More People

Years
  1. 2024 (5377)
Publications
  1. Journal of Clinical Oncology (521)
  2. International Journal of Radiation Oncology, Biology, Physics (186)
  3. Blood (161)
  4. Annals of Oncology (147)
  5. Annals of Surgical Oncology (131)
  6. Laboratory Investigation (91)

More Publications

Publishers
  1. Elsevier Inc. (784)
  2. American Society of Clinical Oncology (580)
  3. Nature Publishing Group (384)
  4. Springer (357)
  5. Oxford University Press (347)
  6. Elsevier Science, Inc. (256)

More Publishers

Results (5377)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • TP53 alterations confer increased risk of leukemic transformation and worse survival as compared to high molecular risk mutations in patients with myeloproliferative neoplasms
    Meeting Abstract

    Handa, S.; Riazat-Kesh, Y. J. R. A.; Butterfield, R. J.; Sivakumar, G.; Venugopal, S.; McGovern, E.; Feld, J.; Tremblay, D.; Elghaity-Beckley, S.; Kremyanskaya, M.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • The association of prior acquired or heritage language exposures with medical students' Spanish language proficiency
    Meeting Abstract

    Diamond, L. C.; Figueroa, J. A. A.; Gregorich, S.; Karliner, L. S.; Pérez-Cordón, C.; González, J.; Ortega, P.
    Journal of General Internal Medicine (2024)

    Fulltext@MSK | Save
  • The effect of biosimilar entry on biologic drug prices in Medicare part B
    Meeting Abstract

    Winn, A.; Abdelaziz, A.; Dusetzina, S. B.; Mitchell, A. P.
    Value in Health (2024)

    Fulltext@MSK | Save
  • Cost-effectiveness (CE) of a multi-cancer early detection (MCED) test varies with population cancer risk
    Meeting Abstract

    Raoof, S.; Kansal, A.; Tafazzoli, A.; Ye, W.; Zou, D.; Fendrick, A. M.
    Value in Health (2024)

    Fulltext@MSK | Save
  • Duration of residence and obesity prevalence among us immigrant adults; Data from the 2019, 2021, and 2022 National Health Interview Survey
    Meeting Abstract

    Claros, M.; Fleishman, A.; Bui, L.; McCarthy, E.; Wee, C. C.
    Journal of General Internal Medicine (2024)

    Fulltext@MSK | Save
  • Matching-adjusted indirect comparison (MAIC) of safety outcomes with MET tyrosine kinase inhibitors (TKIs) in patients with MET exon 14 (METex14) skipping non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Taylor, K.; Veillon, R.; Griesinger, F.; Reinmuth, N.; Ghori, V.; Vioix, H.; Clark, A.; Paik, P.
    Value in Health (2024)

    Fulltext@MSK | Save
  • Updated results and longer follow-up from the AUGMENT-101 phase 2 study of revumenib in all patients with relapsed or refractory (R/R) KMT2Ar acute leukemia
    Meeting Abstract

    Aldoss, I.; Issa, G. C.; Blachly, J. S.; Thirman, M. J.; Mannis, G. N.; Arellano, M. L.; DiPersio, J. F.; Traer, E.; Zwaan, C. M.; Shukla, N.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Gilteritinib results in higher remission and transplant rates than midostaurin but does not increase the post-induction mutational MRD negative rate: Results of the phase 2 randomized PrECOG 0905 study in newly diagnosed FLT3 mutated AML
    Meeting Abstract

    Luger, S.; Chen, L.; Pratz, K. W.; Loghavi, S.; Perl, A. E.; Altman, J. K.; Redner, R. L.; Fathi, A. T.; Qasrawi, A.; Asch, A. S.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Joint preserving tibial shaft trifocal reconstruction with balanced cable bone transport after tumor resection
    Book Section

    Klima, M. F.; Prince, D. E.
    In Rozbruch, S. R.; Fragomen, A. T.; Hamdy, R. C.; Bernstein, M. (Eds.) Limb Lengthening and Reconstruction Surgery Case Atlas. 2nd ed (2024)

    Fulltext@MSK | Save
  • Joint preserving peri-articular reconstruction of distal tibia after high-grade tumor resection
    Book Section

    Prince, D. E.
    In Rozbruch, S. R.; Fragomen, A. T.; Hamdy, R. C.; Bernstein, M. (Eds.) Limb Lengthening and Reconstruction Surgery Case Atlas. 2nd ed (2024)

    Fulltext@MSK | Save